Acute Pancreatitis and Coagulation Study (APK)
Coagulation Disturbances and Thrombosis in Acute Pancreatitis (Koagulopati Och Trombos Vid Akut Pankreatit-APK Studien)
Sponsor: Lund University
A observational or N/A phase clinical study on Acute Pancreatitis, this trial is completed. The trial is conducted by Lund University and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Study Description(click to expand)Inclusion criteria:
Patients with acute pancreatitis admitted to Skåne University Hospital in Malmö
Acute pancreatitis is defined as minimum 2 out of following: amylase levels \>3 times upper reference limit, clinical signs of acute pancreatitis, imaging findings of acute pancreatitis)
Exclusion criteria:
\<18 years of age
\>72 hours from onset of symptom until first sampling
Patients with immunosuppression or autoimmune diseases are excluded from som parts of the study.
Methods: Serum and plasma is sampled repeatedly during the hospital admission. Pre defined protocols are used for data collections of relevant clinical information.
Specific aspects of inflammation, thrombin generation, platelet function and Microparticles will be analysed in serum or plasma during the first consecutive days of acute pancreatitis.
Biomarkers for severe disease as well as correlation between inflammation and coagulopathy will be investigated.
Inclusion criteria:
Patients with acute pancreatitis admitted to Skåne University Hospital in Malmö
Acute pancreatitis is defined as minimum 2 out of following: amylase levels \>3 times upper reference limit, clinical signs of acute pancreatitis, imaging findings of acute pancreatitis)
Exclusion criteria:
\<18 years of age
\>72 hours from onset of symptom until first sampling
Patients with immunosuppression or autoimmune diseases are excluded from som parts of the study.
Methods: Serum and plasma is sampled repeatedly during the hospital admission. Pre defined protocols are used for data collections of relevant clinical information.
Specific aspects of inflammation, thrombin generation, platelet function and Microparticles will be analysed in serum or plasma during the first consecutive days of acute pancreatitis.
Biomarkers for severe disease as well as correlation between inflammation and coagulopathy will be investigated.
Status Flow
Change History
6 versions recorded-
May 4, 2026 — Present [daily]
Completed
-
Sep 2025 — May 2026 [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2024 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
▶ Show 1 earlier version
-
Feb 2022 — May 2024 [monthly]
Recruiting
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
The study aims to investigate pathophysiological changes in coagulation in relation to inflammation in patients with acute pancreatitis. Serum and plasma is sampled repeated days from admission. Analysis will be done after recruitment. Specific biomarkers accuracy for prediction of moderate and severer acute pancreatitis will be calculated.
Contact Information
- Lund University
- Region Skane
For direct contact, visit the study record on ClinicalTrials.gov .